These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34700291)

  • 1. Opportunistic mycoses in COVID-19 patients/survivors: Epidemic inside a pandemic.
    Kuchi Bhotla H; Balasubramanian B; Meyyazhagan A; Pushparaj K; Easwaran M; Pappusamy M; Alwin Robert A; Arumugam VA; Tsibizova V; Msaad Alfalih A; Aljowaie RM; Saravanan M; Di Renzo GC
    J Infect Public Health; 2021 Nov; 14(11):1720-1726. PubMed ID: 34700291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Fungal Infection, Immune Response, and Clinical Challenge-a Perspective During COVID-19 Pandemic.
    Naveen KV; Saravanakumar K; Sathiyaseelan A; MubarakAli D; Wang MH
    Appl Biochem Biotechnol; 2022 Sep; 194(9):4244-4257. PubMed ID: 35648275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic mycoses: a potential alert for complications in COVID-19 patients.
    Segrelles-Calvo G; de S Araújo GR; Frases S
    Future Microbiol; 2020 Sep; 15():1405-1413. PubMed ID: 33085538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to fungi in the lung.
    Heung LJ; Wiesner DL; Wang K; Rivera A; Hohl TM
    Semin Immunol; 2023 Mar; 66():101728. PubMed ID: 36841146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and Fungal infections: a double debacle.
    Mina S; Yaakoub H; Annweiler C; Dubée V; Papon N
    Microbes Infect; 2022; 24(8):105039. PubMed ID: 36030024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycotic infection prevalence among patients undergoing bronchoalveolar lavage with search of SARS-CoV-2 after two negative nasopharyngeal swabs.
    Patrucco F; Airoldi C; Falaschi Z; Bellan M; Castello LM; Filippone F; Matranga S; Masellis S; Smeriglia A; Solidoro P; Balbo PE; Gavelli F
    J Breath Res; 2021 Sep; 15(4):. PubMed ID: 34464944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention.
    Suleyman G; Alangaden GJ
    Infect Dis Clin North Am; 2021 Dec; 35(4):1027-1053. PubMed ID: 34752219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19-associated fungal infections.
    Hoenigl M; Seidel D; Sprute R; Cunha C; Oliverio M; Goldman GH; Ibrahim AS; Carvalho A
    Nat Microbiol; 2022 Aug; 7(8):1127-1140. PubMed ID: 35918423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Geotrichum infection in an immunocompetent host with SARS-CoV-2 infection.
    Selvan K; Mutlu G
    Tuberk Toraks; 2021 Sep; 69(3):421-424. PubMed ID: 34581166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent.
    Bhargava D; Ahirwal R; Dubey S; Gurjar P; Pandey A; Beena S; Koneru G
    Head Neck Pathol; 2022 Sep; 16(3):645-650. PubMed ID: 34751896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran.
    Salehi M; Ahmadikia K; Badali H; Khodavaisy S
    Mycopathologia; 2020 Aug; 185(4):607-611. PubMed ID: 32737746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
    Ezeokoli OT; Pohl CH
    S Afr Med J; 2020 Oct; 110(11):1081-1085. PubMed ID: 33403982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histomorphological features of mucormycosis with rise and fall of COVID-19 pandemic.
    Ganesan N; Sivanandam S
    Pathol Res Pract; 2022 Aug; 236():153981. PubMed ID: 35749915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive fungal diseases during COVID-19: We should be prepared.
    Gangneux JP; Bougnoux ME; Dannaoui E; Cornet M; Zahar JR
    J Mycol Med; 2020 Jun; 30(2):100971. PubMed ID: 32307254
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.
    Gurunathan S; Lee AR; Kim JH
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review on SARS-CoV-2-associated fungal coinfections.
    Soni S; Namdeo Pudake R; Jain U; Chauhan N
    J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-COVID-19 Fungal Infection in the Aged Population.
    Chavda VP; Mishra T; Kamaraj S; Punetha S; Sengupta O; Joshi Y; Vuppu S; Vaghela D; Vora L
    Vaccines (Basel); 2023 Feb; 11(3):. PubMed ID: 36992139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.